Eye Care Updates

Contacts
8Sep, 2016

“SMART” CONTACTS

By: | Tags: , , , , ,

One of the ways that ophthalmologists assess glaucoma patients’ risk of blindness is to monitor their “intraocular pressure” (inner eye pressure), which can rise high enough to damage their optic nerves. Such is the case with patients suffering from “open-angle glaucoma,” which accounts for about 90% of all cases. With this most common form of glaucoma, the eyes’ drainage canals become blocked over time, causing an increase of intraocular pressure and any resultant optic-nerve damage. With all this in mind, it is quite notable that researchers have recently developed a […]
READ MORE

fallen elderly
2Sep, 2016

FALL PREVENTION

By: | Tags: , , ,

About one-third of individuals over age 65 fall each year, and the risk of falling increases proportionally with age. By age 80, over half of seniors fall annually. As attention continues to focus on preventing falls (and consequent bone fractures, which may severely inhibit personal freedom), seniors may rightfully enlist the help of physical therapists, orthopedic surgeons, and even home remodelers. They may also want to add ophthalmologists to their lists. Not only has research shown that poor visual acuity increases seniors’ risk of falling, but there is also evidence […]
READ MORE

amd
21Jul, 2016

NEW LENS TREATMENT FOR AMD

By: | Tags: , , , , ,

Age-related macular degeneration (AMD), the leading cause of severe vision loss and legal blindness in people over the age of 65, is an eye condition that leads to deterioration of the central portion of the retina (the macula). As a result, the “straight-ahead” vision needed to read, drive, watch TV, identify faces, and perform fine-detailed work is lost. Nutritional therapy is currently the only known treatment for the more common “dry” form of the disease, while laser photocoagulation and injections are the treatment for sealing leaking blood vessels associated with […]
READ MORE

research
16Feb, 2016

NEW TREATMENT FOR MACULAR DEGENERATION?

By: | Tags: , , ,

Because “age-related macular degeneration” (AMD) is the leading cause of vision loss and blindness in Americans aged 65 years and older, any information about a potential new treatment is welcomed. As a starting point in searching for new ways to treat AMD, researchers noted that people with highly pigmented and darker-colored eyes are less prone to developing AMD and more likely to have higher levels of a chemical called L-DOPA, which is prescribed to Parkinson’s patients (who have low levels of this dopamine precursor in their brains). When researchers examined […]
READ MORE